Marc Iskowitz

Marc Iskowitz

Marc Iskowitz has covered healthcare marketing, advertising and media for MM&M since 2005, but has followed the medical beat in a variety of roles since ‘96 or so. He has also moderated judging panels for the MM&M Awards. If you have story ideas, tips or criticism, e-mail me. And feel free to follow me on Twitter.

Most Recent Articles by Marc Iskowitz

The New Reality for Pharma Marketers is Drug Pricing

The New Reality for Pharma Marketers is Drug Pricing

By

My hope is that all of us do a better job of focusing on value.

How We Picked the Health Influencer 50

How We Picked the Health Influencer 50

By

Each of this year's Influencers wields significant influence at a major health-related organization and boasts high-profile accomplishments, oftentimes ahead of the aforementioned pain-of- change curve.

How five therapies changed the course of pharma history

How five therapies changed the course of pharma history

By

And why the stories behind thalidomide, Naprosyn, AZT, cardiology stents, and Zaltrap still resonate.

MM&M's First 50 Years: A Look at What's Changed for Pharma, and What Hasn't

MM&M's First 50 Years: A Look at What's Changed for Pharma, and What Hasn't

By

Some innovations are still emerging, while others seem more elusive than ever. You'll find many moments whose impact resonates through time.

Five-Figure Salaries. Big Hair. Pharma, 1987

Five-Figure Salaries. Big Hair. Pharma, 1987

By

When the Career and Salary Survey made its debut, in 1987, Eli Lilly's Prozac led the list of mass-market drug launches and AIDS therapy had taken a big step forward with the approval of GlaxoSmithKline's AZT, a year earlier.

More Articles by Marc Iskowitz

OPINION

Email Newsletters